These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3109490)

  • 21. The toxicity of melanin precursors.
    Graham DG; Tiffany SM; Vogel FS
    J Invest Dermatol; 1978 Feb; 70(2):113-6. PubMed ID: 413870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. gamma-Glutamyl transpeptidase, tyrosinase, and 5-S-cysteinyldopa production in melanoma cells.
    Mojamdar M; Ichihashi M; Mishima Y
    J Invest Dermatol; 1983 Aug; 81(2):119-21. PubMed ID: 6135733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-S-cysteinyldopa as a substrate for tyrosinase.
    Hansson C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1980; 60(5):399-402. PubMed ID: 6162310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enkephalins and exorphins oxidation by tyrosinase.
    Rosei MA; Antonilli L; Coccia R; Foppoli C
    Biochem Int; 1989 Dec; 19(6):1183-93. PubMed ID: 2517578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of catalase on the inactivation of tyrosinase by ascorbic acid and by cysteine or glutathione.
    Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(3):209-14. PubMed ID: 6192633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopachrome conversion activity in Aedes aegypti: significance during melanotic encapsulation of parasites and cuticular tanning.
    Li J; Zhao X; Christensen BM
    Insect Biochem Mol Biol; 1994 Dec; 24(10):1043-9. PubMed ID: 7703986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidation of 3,4-dihydroxybenzylamine affords 3,4-dihydroxybenzaldehyde via the quinone methide intermediate.
    Sugumaran M
    Pigment Cell Res; 1995 Oct; 8(5):250-4. PubMed ID: 8789199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A kinetic study of the melanization pathway between L-tyrosine and dopachrome.
    Cabanes J; García-Cánovas F; Lozano JA; García-Carmona F
    Biochim Biophys Acta; 1987 Feb; 923(2):187-95. PubMed ID: 3101741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct evidence for quinone-quinone methide tautomerism during tyrosinase catalyzed oxidation of 4-allylcatechol.
    Sugumaran M; Bolton J
    Biochem Biophys Res Commun; 1995 Aug; 213(2):469-74. PubMed ID: 7646501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the reactions between human tyrosinase, superoxide anion, hydrogen peroxide and thiols.
    Wood JM; Schallreuter KU
    Biochim Biophys Acta; 1991 Aug; 1074(3):378-85. PubMed ID: 1653610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of tyrosine by Microspira tyrosinatica: a new intermediate [2,4,5-trihydroxyphenylalanine (6-hydroxydopa)] in the tyrosinase reaction.
    Lunt DO; Evans WC
    Biochem Soc Trans; 1976; 4(3):491-2. PubMed ID: 826428
    [No Abstract]   [Full Text] [Related]  

  • 32. A reactive ortho-quinone generated by tyrosinase-catalyzed oxidation of the skin depigmenting agent monobenzone: self-coupling and thiol-conjugation reactions and possible implications for melanocyte toxicity.
    Manini P; Napolitano A; Westerhof W; Riley PA; d'Ischia M
    Chem Res Toxicol; 2009 Aug; 22(8):1398-405. PubMed ID: 19610592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of a kinetic model for melanin biosynthesis pathway.
    Rodríguez-López JN; Tudela J; Varón R; García-Carmona F; García-Cánovas F
    J Biol Chem; 1992 Feb; 267(6):3801-10. PubMed ID: 1740428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopa oxidation and tyrosine oxygenation by human melanoma tyrosinase.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(6):468-75. PubMed ID: 6198834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harding-passey mouse-melanoma tyrosinase inactivation by reaction products and activation by L-epinephrine.
    Miranda M; Botti D
    Gen Pharmacol; 1983; 14(2):231-7. PubMed ID: 6404691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evidence for covalent lipoyl adduction with dopaquinone following tyrosinase-catalyzed oxidation.
    Tsuji-Naito K; Hatani T; Okada T; Tehara T
    Biochem Biophys Res Commun; 2006 Apr; 343(1):15-20. PubMed ID: 16527255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Function of dopachrome oxidoreductase and metal ions in dopachrome conversion in the eumelanin pathway.
    Leonard LJ; Townsend D; King RA
    Biochemistry; 1988 Aug; 27(16):6156-9. PubMed ID: 3142518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of tyrosinase by indole compounds and reaction products. Protection by albumin.
    Miranda M; Urbani G; Di Vito L; Botti D
    Biochim Biophys Acta; 1979 Jul; 585(3):398-404. PubMed ID: 114228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5,6-Dihydroxyindole oxidation by mammalian, mushroom and amphibian tyrosinase preparations.
    Miranda M; Botti D; Bonfigli A; Arcadi A
    Biochim Biophys Acta; 1985 Aug; 841(2):159-65. PubMed ID: 3926006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tyrosinase-like activity in normal human substantia nigra.
    Miranda M; Botti D; Bonfigli A; Ventura T; Arcadi A
    Gen Pharmacol; 1984; 15(6):541-4. PubMed ID: 6441736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.